Nab-paclitaxel plus bevacizumab for patients with metastatic extrapulmonary neuroendocrine carcinoma: a phase 2 single-arm study.

EClinicalMedicine · 2025 · PMC12595278 · PMID 41209655

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

While gastric origin NECs demonstrated a trend toward higher ORR compared to those with NECs originating from other primary sites with borderline statistically significant, the differences in mPFS or mOS also did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.